Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Developmental Psychomotor Disorders

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Developmental Psychomotor Disorders in 4 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parrott, AC2
Buchanan, T2
Heffernan, TM1
Scholey, A1
Ling, J2
Rodgers, J2
Sumnall, HR1
Jerome, L1
Doblin, R1
Mithoefer, MC1
Scholey, AB1
Heffernan, T1
Uys, JD1
Niesink, RJ1

Reviews

1 review available for n-methyl-3,4-methylenedioxyamphetamine and Developmental Psychomotor Disorders

ArticleYear
Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
    Drug and alcohol review, 2005, Volume: 24, Issue:4

    Topics: Anxiety; Body Temperature; Depression; Dopamine; Hallucinogens; Humans; Hydroxybutyrates; N-Methyl-3

2005

Other Studies

3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Developmental Psychomotor Disorders

ArticleYear
Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.
    Psychopharmacology, 2003, Volume: 167, Issue:4

    Topics: Brain; Dopamine; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Parki

2003
Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.
    Psychopharmacology, 2004, Volume: 171, Issue:2

    Topics: Animals; Dopamine; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Neu

2004
The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).
    Psychopharmacology, 2004, Volume: 171, Issue:2

    Topics: Animals; Clinical Trials as Topic; Dopamine; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-meth

2004